{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=radioactive+drug+%28tracer%29&page=3", "query": { "intervention": "radioactive drug (tracer)", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 120, "total_pages": 12, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=radioactive+drug+%28tracer%29&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=radioactive+drug+%28tracer%29&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T18:55:43.308Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03872778", "title": "[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Neoplasms" ], "interventions": [ { "name": "[177Lu]-NeoB", "type": "DRUG" }, { "name": "[68Ga]-NeoB", "type": "DRUG" }, { "name": "LCZ696", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advanced Accelerator Applications", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2019-07-24", "completion_date": "2025-11-27", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 6, "location_summary": "Duarte, California • Stanford, California • Baltimore, Maryland + 3 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Portland", "state": "Oregon" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03872778" }, { "nct_id": "NCT04538950", "title": "PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "PET/CT", "type": "DIAGNOSTIC_TEST" }, { "name": "radioactive drug (tracer)", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2020-08-14", "completion_date": "2022-05-19", "has_results": true, "last_update_posted_date": "2023-09-13", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04538950" }, { "nct_id": "NCT04377152", "title": "Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Prostate Cancer", "Prostate", "Prostate Adenocarcinoma" ], "interventions": [ { "name": "68Gallium-PSMA-11", "type": "DRUG" }, { "name": "Positron Emission Tomography (PET)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2021-03-01", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04377152" }, { "nct_id": "NCT02120014", "title": "Blood Volume and Hemodynamic Analysis in Patients With Chronic Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congestive Heart Failure" ], "interventions": [ { "name": "blood volume measurement", "type": "PROCEDURE" }, { "name": "venous plethysmography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2014-04-21", "completion_date": "2018-07-06", "has_results": false, "last_update_posted_date": "2018-10-24", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02120014" }, { "nct_id": "NCT07781852", "title": "Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Bladder Cancer", "Glioma", "Glioblastoma (GBM)", "Breast Cancer", "Colorectal Cancer", "Esophageal Cancer", "Gastric Cancer (GC)", "Pharynx Cancer", "Oral Cavity Cancer", "Kidney Cancer", "Liver Cancer", "Lung Cancer (NSCLC)", "Ovarian Cancer", "Pancreatic Cancer", "PDAC - Pancreatic Ductal Adenocarcinoma", "Prostate Cancer" ], "interventions": [ { "name": "[64Cu]CM500", "type": "DRUG" }, { "name": "[68Ga]CM500", "type": "DRUG" }, { "name": "PET/MR", "type": "DEVICE" }, { "name": "PET/CT", "type": "DEVICE" }, { "name": "Blood Collection", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DEVICE", "PROCEDURE" ], "sponsor": "Lumina Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-09-01", "completion_date": "2027-09-01", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 3, "location_summary": "Boston, Massachusetts • Grand Rapids, Michigan • New York, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07781852" }, { "nct_id": "NCT04105634", "title": "Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Cardiac Amyloidosis" ], "interventions": [ { "name": "FNOS", "type": "DRUG" }, { "name": "Florbetaben", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2019-10-01", "completion_date": "2024-10-14", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04105634" }, { "nct_id": "NCT07156565", "title": "Actinium Therapy for Late-stage Aggressive Sarcomas", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Soft Tissue Sarcoma" ], "interventions": [ { "name": "[Ac 225]RTX-2358", "type": "DRUG" }, { "name": "[Cu64]LNTH-1363S", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Ratio Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2025-11-12", "completion_date": "2032-01", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 5, "location_summary": "Los Angeles, California • Rochester, Minnesota • New York, New York + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07156565" }, { "nct_id": "NCT07020117", "title": "A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Urothelial Carcinoma Bladder", "Triple Negative Breast Cancer (TNBC)", "Hormone Receptor Positive Breast Adenocarcinoma", "Non Small Cell Lung Cancer", "Cervical Adenocarcinoma", "Colorectal Adenocarcinoma", "Head and Neck Cancer" ], "interventions": [ { "name": "[225Ac]Ac-AKY-1189 (therapeutic)", "type": "DRUG" }, { "name": "[64Cu]Cu-AKY-1189 (imaging)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aktis Oncology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2025-08-22", "completion_date": "2032-06", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 14, "location_summary": "Duarte, California • Irvine, California • Miami, Florida + 10 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07020117" }, { "nct_id": "NCT06736418", "title": "Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Small-Cell Lung Cancer (SCLC)", "Large Cell Neuroendocrine Carcinoma of the Lung" ], "interventions": [ { "name": "225Ac-ABD147", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abdera Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2025-03-10", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 12, "location_summary": "Newport Beach, California • San Francisco, California • Santa Monica, California + 9 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06736418" }, { "nct_id": "NCT03939780", "title": "Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy", "Alzheimer Disease" ], "interventions": [ { "name": "[F18]RO-948", "type": "DIAGNOSTIC_TEST" }, { "name": "[F18]MK-6240", "type": "DIAGNOSTIC_TEST" }, { "name": "[F18]AV1451", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "50 Years to 100 Years" }, "enrollment_count": 0, "start_date": "2020-01", "completion_date": "2023-04", "has_results": false, "last_update_posted_date": "2020-02-11", "last_synced_at": "2026-10-10T18:55:43.308Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03939780" } ] }